BCLAF1 and hepatocellular carcinoma: Previous studies have found that BCLAF1 is abnormally highly expressed in HCC and that high levels of BCLAF1 are strongly associated with poor prognosis in HCC patients [22–25], as validated by our data (Fig. 1).